financetom
Business
financetom
/
Business
/
Centrus Energy Q3 revenue misses estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Centrus Energy Q3 revenue misses estimates
Nov 5, 2025 2:46 PM

Overview

* Centrus Q3 revenue increased 30% yr/yr to $74.9 mln, but missed analyst expectations

* Net income for Q3 2025 was $3.9 mln, compared to a net loss last year

* Company closed $805 mln convertible notes offering, increasing cash to $1.6 bln

Outlook

* Company plans expansion of Ohio enrichment plant with KHNP and POSCO

* Centrus notes high market demand for U.S.-owned enrichment supply

Result Drivers

* GOVERNMENT WAIVERS - Secured U.S. government waivers for 2026 and 2027 Russian deliveries, reducing geopolitical risks

* PLANT EXPANSION - Agreement with KHNP and POSCO International to support Piketon, Ohio enrichment plant expansion

* HIRING FOR EXPANSION - Began hiring ahead of planned expansion of enrichment plant

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Miss $74.9 $79.43

Revenue mln mln (13

Analysts

)

Q3 Net $3.90

Income mln

Q3 Gross -$4.30

Profit mln

Q3 -$16.60

Operatin mln

g Income

Q3 -$8 mln

Pretax

Profit

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy", 5 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the uranium peer group is "buy"

* Wall Street's median 12-month price target for Centrus Energy Corp ( LEU ) is $270.68, about 20.3% below its November 5 closing price of $325.73

* The stock recently traded at 83 times the next 12-month earnings vs. a P/E of 61 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Nike tops Q4 sales, profit estimates as CEO doubles down on sports focus
Nike tops Q4 sales, profit estimates as CEO doubles down on sports focus
Jun 26, 2025
June 26 (Reuters) - Nike ( NKE ) reported a smaller-than-expected drop in fourth-quarter revenue and beat profit estimates on Thursday, as CEO Elliott Hill's strategy to focus product innovation and marketing around sports begins to pay off. The company, which has been grappling with competition in the running space, has heavily invested in running shoes and sneaker lines such...
Bausch + Lomb Closes Floating Rate Note Offering, Refinances Credit Facilities
Bausch + Lomb Closes Floating Rate Note Offering, Refinances Credit Facilities
Jun 26, 2025
05:00 PM EDT, 06/26/2025 (MT Newswires) -- Bausch + Lomb ( BLCO ) closed an upsized offering of 675 million euros ($789.6 million) in senior secured floating rate notes due Jan. 15, 2031. The notes bear interest at the three-month Euro Interbank Offered Rate plus 3.875%, reset quarterly, the company said Thursday in a statement. The company also completed a...
Achieve Life Sciences Seeks FDA Approval for Smoking Cessation Drug, Partners With Omnicom for Launch
Achieve Life Sciences Seeks FDA Approval for Smoking Cessation Drug, Partners With Omnicom for Launch
Jun 26, 2025
05:00 PM EDT, 06/26/2025 (MT Newswires) -- Achieve Life Sciences ( ACHV ) said Thursday it submitted a new drug application to the US Food and Drug Administration for cytisinicline as a treatment for nicotine dependence in smoking cessation. The application is supported by efficacy and safety data from two phase 3 trials, the company said. Separately, Achieve said it...
Copyright 2023-2026 - www.financetom.com All Rights Reserved